Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Down 52.9% in July

Posted by on Jul 29th, 2026

Advanced Medical Isotope Corporation (OTCMKTS:RDGL – Get Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totaling 66,933 shares, a decline of 52.9% from the June 30th total of 142,100 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 8,132,292 shares, the short-interest ratio is presently 0.0 days.

Advanced Medical Isotope Stock Down 2.7%

OTCMKTS RDGL opened at $0.06 on Wednesday. The stock has a market capitalization of $28.40 million, a P/E ratio of -5.75 and a beta of -0.75. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.14. The firm has a 50-day moving average price of $0.06 and a 200 day moving average price of $0.07.

Advanced Medical Isotope Company Profile

(Get Free Report)

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.

Featured Stories

Receive News & Ratings for Advanced Medical Isotope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Isotope and related companies with MarketBeat.com's FREE daily email newsletter.